Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Acta Psychiatr Scand ; 129(4): 286-95, 2014 Apr.
Article in English | MEDLINE | ID: mdl-23834587

ABSTRACT

OBJECTIVE: The objective of this study was to assess the cost-effectiveness of three empirically supported treatments for panic disorder with or without agoraphobia: cognitive behavioral therapy (CBT), pharmacotherapy using a selective serotonin reuptake inhibitor (SSRI), or the combination of both (CBT+SSRI). METHOD: Cost-effectiveness was examined based on the data from a multicenter randomized controlled trial. The Hamilton Anxiety Rating Scale was selected as a primary health outcome measure. Data on costs from a societal perspective (i.e., direct medical, direct non-medical, and indirect non-medical costs) were collected in the study sample (N=150) throughout a 24-month period in which patients received active treatment during the first twelve months and were seen twice for follow-up in the next twelve months. RESULTS: Total costs were largely influenced by costs of the interventions and productivity losses. The mean total societal costs were lower for CBT as compared to SSRI and CBT+SSRI. Costs of medication use were substantial for both SSRI and CBT+SSRI. When examining the balance between costs and health outcomes, both CBT and CBT+SSRI led to more positive outcomes than SSRI. CONCLUSION: Cognitive behavioral therapy is associated with the lowest societal costs. Cognitive behavioral therapy and CBT+SSRI are more cost-effective treatments for panic disorder with or without agoraphobia as compared to SSRI only.


Subject(s)
Cognitive Behavioral Therapy , Cost-Benefit Analysis , Panic Disorder/economics , Panic Disorder/therapy , Selective Serotonin Reuptake Inhibitors , Adolescent , Adult , Cognitive Behavioral Therapy/economics , Cognitive Behavioral Therapy/methods , Combined Modality Therapy/economics , Combined Modality Therapy/methods , Humans , Male , Middle Aged , Panic Disorder/drug therapy , Selective Serotonin Reuptake Inhibitors/economics , Selective Serotonin Reuptake Inhibitors/pharmacology , Treatment Outcome , Young Adult
2.
Acta Psychiatr Scand ; 117(4): 260-70, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18307586

ABSTRACT

OBJECTIVE: To establish whether the combination of cognitive-behavioral therapy (CBT) and pharmacotherapy (SSRI) was more effective in treating panic disorder (PD) than either CBT or SSRI alone, and to evaluate any differential effects between the mono-treatments. METHOD: Patients with PD (n = 150) with or without agoraphobia received CBT, SSRI or CBT + SSRI. Outcome was assessed after 9 months, before medication taper. RESULTS: CBT + SSRI was clearly superior to CBT in both completer and intent-to-treat analysis (ITT). Completer analysis revealed superiority of CBT + SSRI over SSRI on three measures and no differences between CBT and SSRI. ITT analysis revealed superiority of SSRI over CBT on four measures and no differences between CBT + SSRI and SSRI. CONCLUSION: Both the mono-treatments (CBT and SSRI) and the combined treatment (CBT + SSRI) proved to be effective treatments for PD. At post-test, CBT + SSRI was clearly superior to CBT, but differences between CBT + SSRI and SSRI, and between SSRI and CBT, were small.


Subject(s)
Agoraphobia/therapy , Cognitive Behavioral Therapy/methods , Panic Disorder/therapy , Selective Serotonin Reuptake Inhibitors/therapeutic use , Adolescent , Adult , Agoraphobia/drug therapy , Anxiety Disorders/diagnosis , Anxiety Disorders/therapy , Combined Modality Therapy , Female , Humans , Male , Middle Aged , Panic Disorder/diagnosis , Panic Disorder/drug therapy , Severity of Illness Index , Surveys and Questionnaires , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...